The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
A senior Russian military official, Major General Yaroslav Moskalik, was killed on Friday in a…
The Center for Digital Assets Research (CeDAR) at LUMS was officially launched on April 24,…
International Packaging Films Limited (IPAK) Group has recorded 66% increase in its revenues for the…
The Aga Khan University (AKU) marked World Malaria Day with the launch of the Thatta…
Researchers at Stanford University have unveiled a breakthrough in solar technology: a new type of…
The National Disaster Management Authority (NDMA) has warned of unstable weather conditions across several parts…
This website uses cookies.
